Amylin Pharmaceuticals is a leading biopharmaceutical company based in Boulder, CO, dedicated to transforming the future of healthcare through the power of science. With a focus on precision medicine and transformative science, they develop next-generation therapeutics in various therapy areas, including oncology, cardiovascular, renal and metabolism, respiratory, immunology, vaccines, and rare diseases.
Committed to making a positive impact on society and the planet, Amylin Pharmaceuticals prioritizes access to healthcare, environmental protection, ethics, transparency, and partnerships. They collaborate with AstraZeneca and have a robust pipeline of 167 projects, employing a research approach that targets different molecular causes of diseases, identifies new biomarkers, and aims for accurate patient classification. With their dedication to inclusion and diversity, Amylin Pharmaceuticals is at the forefront of advancing healthcare innovation.
Generated from the website
